Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4569 studies found for:    Open Studies | "Vascular Diseases"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Vascular Diseases" (4569 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Recruiting Pulmonary Vascular Disease Phenomics Program PVDOMICS
Condition: Pulmonary Vascular Disease
Intervention: Other: No Intervention
2 Not yet recruiting Multi-spectral Imaging to Assess Wounds in Peripheral Vascular Disease Patients
Condition: Peripheral Vascular Disease Patient
Intervention: Device: Multi-spectral Imaging Device (MSID)
3 Recruiting Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Intervention: Device: Everolimus-Eluting Bioresorbable Vascular Scaffold (ABSORB)
4 Not yet recruiting Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Interventions: Drug: Lucentis® (Raibizumab) double-dose;   Drug: Lucentis® (Raibizumab) regular-dose
5 Recruiting Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy
Condition: Cardiac Allograft Vasculopathy
Interventions: Drug: Perflutren Lipid Microsphere;   Procedure: RTMPE
6 Not yet recruiting Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)
Condition: Symtomatic Macular Polypoidal Choroidal Vasculopathy
Intervention: Biological: Intravitreous aflibercept injection
7 Recruiting Shockwave Therapy in Lower Limb Intermittent Calf Claudication
Condition: Peripheral Vascular Disease
Intervention: Device: Extracorporeal shockwave therapy
8 Recruiting Assessment of Short-term Effect of L-Citrulline on Endothelial Function and Vasodilation in Known CAD Patients
Condition: Vascular Disease
Interventions: Drug: L-Citrulline;   Drug: placebo
9 Recruiting Manchester Antenatal Vascular Service
Condition: Vascular Disease
Intervention: Other: no intervention
10 Not yet recruiting Aclarubicin for the Treatment of Retinal Vasculopathy With Cerebral Leukodystrophy
Conditions: Vasculopathy, Retinal, With Cerebral Leukodystrophy;   Cerebroretinal Vasculopathy, Hereditary
Intervention: Drug: aclarubicin
11 Recruiting Study the Clinical Outcome of Ayurvedic SUVED and Reimmugen (Colostrum), in Patients of Vascular Disease
Conditions: Coronary Artery Disease;   Cerebro Vascular Disease;   Ischemic Heart Disease;   Deep Vein Thrombosis;   Peripheral Arterial Diseases;   Vascular Disease
Intervention: Drug: Ayurvedic Suved and Whole cow colostrum
12 Recruiting Chinese Arteriosclerosis Series Evaluation-She Minority Study
Condition: Vascular Disease
Intervention:
13 Recruiting Vascular EffectS of regUlar Cigarettes Versus electronIc Cigarette USe
Condition: Vascular Diseases
Interventions: Device: electronic cigarette + 16mg nicotine & flavor;   Other: electronic cigarette + 0mg nicotine & flavor;   Other: Tobacco cigarette
14 Not yet recruiting Photoplethysmography Detects Changes in Vascular Tone
Condition: Vascular Diseases
Intervention:
15 Recruiting Evaluation of Dynamic Pulmonary Vascular Resistance in Patients With Closed Ventricular Septal Defect
Condition: Pulmonary Vascular Disease
Intervention: Other: The intervention is performing an exercise test
16 Recruiting Physiologic Assessment of Microvascular Function in Heart Transplant Patients
Condition: Cardiac Allograft Vasculopathy
Intervention:
17 Not yet recruiting Initial Versus Delayed PDT Combination With Conbercept in PCV
Condition: Polypoidal Choroidal Vasculopathy
Interventions: Drug: conbercept;   Procedure: Initial PDT;   Procedure: Delayed PDT
18 Recruiting Is Peri-operative Hyperoxemia a Risk Factor for Postoperative Complications?
Condition: Vascular Disease
Interventions: Drug: Oxygen;   Other: Air
19 Recruiting Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy
Condition: Polypoidal Choroidal Vasculopathy
Interventions: Drug: IVT Aflibercept; Verteporfin PDT;   Drug: IVT Aflibercept; Sham PDT
20 Recruiting Registry of the Magellan Robotic System
Condition: Peripheral Vascular Disease
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.